Esben Laugesen

1.8k total citations
61 papers, 947 citations indexed

About

Esben Laugesen is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Esben Laugesen has authored 61 papers receiving a total of 947 indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Cardiology and Cardiovascular Medicine, 16 papers in Endocrinology, Diabetes and Metabolism and 15 papers in Surgery. Recurrent topics in Esben Laugesen's work include Cardiovascular Health and Disease Prevention (34 papers), Blood Pressure and Hypertension Studies (18 papers) and Heart Rate Variability and Autonomic Control (15 papers). Esben Laugesen is often cited by papers focused on Cardiovascular Health and Disease Prevention (34 papers), Blood Pressure and Hypertension Studies (18 papers) and Heart Rate Variability and Autonomic Control (15 papers). Esben Laugesen collaborates with scholars based in Denmark, United States and United Kingdom. Esben Laugesen's co-authors include Per Løgstrup Poulsen, Jakob Appel Østergaard, Troels Krarup Hansen, Richard David Leslie, Klavs Würgler Hansen, Jesper Fleischer, Søren Tang Knudsen, Kristian Løkke Funck, Jens Sandahl Christiansen and Simon Lebech Cichosz and has published in prestigious journals such as SHILAP Revista de lepidopterología, Diabetes Care and Kidney International.

In The Last Decade

Esben Laugesen

57 papers receiving 938 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Esben Laugesen Denmark 18 470 303 244 180 129 61 947
B. Lormeau France 17 417 0.9× 271 0.9× 305 1.3× 65 0.4× 122 0.9× 33 938
Satoki Homma Japan 14 299 0.6× 151 0.5× 180 0.7× 102 0.6× 128 1.0× 33 773
Jye‐Yu C. Backlund United States 17 284 0.6× 497 1.6× 226 0.9× 224 1.2× 82 0.6× 25 1.1k
Amanda J. Cox United States 16 271 0.6× 196 0.6× 106 0.4× 97 0.5× 60 0.5× 33 713
Xueqi Li China 13 388 0.8× 130 0.4× 267 1.1× 47 0.3× 57 0.4× 45 758
Valentina Milani Italy 18 473 1.0× 149 0.5× 249 1.0× 30 0.2× 93 0.7× 57 1.1k
Yoshihiko Sakai Japan 15 491 1.0× 90 0.3× 217 0.9× 69 0.4× 55 0.4× 69 804
E Hartter Austria 16 447 1.0× 144 0.5× 230 0.9× 49 0.3× 159 1.2× 34 901
Jacek Kądziela Poland 14 672 1.4× 103 0.3× 287 1.2× 29 0.2× 130 1.0× 62 1.0k
Jennifer Linge Sweden 17 169 0.4× 228 0.8× 138 0.6× 57 0.3× 477 3.7× 36 980

Countries citing papers authored by Esben Laugesen

Since Specialization
Citations

This map shows the geographic impact of Esben Laugesen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Esben Laugesen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Esben Laugesen more than expected).

Fields of papers citing papers by Esben Laugesen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Esben Laugesen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Esben Laugesen. The network helps show where Esben Laugesen may publish in the future.

Co-authorship network of co-authors of Esben Laugesen

This figure shows the co-authorship network connecting the top 25 collaborators of Esben Laugesen. A scholar is included among the top collaborators of Esben Laugesen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Esben Laugesen. Esben Laugesen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Funck, Kristian Løkke, et al.. (2025). Colchicine mitigates arterial stiffness in high-risk patients with type 2 diabetes: a randomized placebo-controlled trial. European Journal of Preventive Cardiology. 33(5). 707–714.
2.
Funck, Kristian Løkke, et al.. (2024). Separate and combined effects of empagliflozin and semaglutide on vascular function: A 32‐week randomized trial. Diabetes Obesity and Metabolism. 26(5). 1624–1635. 13 indexed citations
3.
4.
Ringgaard, Steffen, Christoffer Laustsen, Henrik Birn, et al.. (2024). The effects of semaglutide, empagliflozin and their combination on the kidney sodium signal from magnetic resonance imaging: A prespecified, secondary analysis from a randomized, clinical trial. Journal of Diabetes and its Complications. 38(2). 108673–108673. 3 indexed citations
5.
Peters, Christian D., Kevin Kris Warnakula Olesen, Esben Laugesen, et al.. (2023). Invasively Measured Aortic Systolic Blood Pressure and Office Systolic Blood Pressure in Cardiovascular Risk Assessment in CKD. Kidney International Reports. 9(2). 296–311. 1 indexed citations
6.
7.
8.
Funck, Kristian Løkke, Esben Laugesen, Brian Stausbøl‐Grøn, et al.. (2021). Arterial stiffness and progression of cerebral white matter hyperintensities in patients with type 2 diabetes and matched controls: a 5-year cohort study. Diabetology & Metabolic Syndrome. 13(1). 71–71. 9 indexed citations
9.
Laugesen, Esben, et al.. (2020). P168 Prevalence and characteristics of cardiovascular autonomic dysfunction in patients with systemic lupus erythematosus. Poster presentations. A112.1–A112. 1 indexed citations
10.
Kristensen, Peter Lommer, Klavs Würgler Hansen, Esben Laugesen, et al.. (2020). Effect of 12‐week continuous positive airway pressure therapy on glucose levels assessed by continuous glucose monitoring in people with type 2 diabetes and obstructive sleep apnoea; a randomized controlled trial. Endocrinology Diabetes & Metabolism. 4(2). e00148–e00148. 13 indexed citations
11.
Funck, Kristian Løkke, et al.. (2019). Retinal vessel reactivity is not attenuated in patients with type 2 diabetes compared with matched controls and is associated with peripheral endothelial function in controls. Journal of Diabetes and its Complications. 33(9). 641–647. 7 indexed citations
12.
Laugesen, Esben, et al.. (2019). Differential vascular effects of aspirin in people with Type 2 diabetes without cardiovascular disease and matched controls without diabetes. Diabetic Medicine. 36(9). 1141–1148. 2 indexed citations
13.
Winther, Simon, Christian D. Peters, Esben Laugesen, et al.. (2019). Aortic Calcification Affects Noninvasive Estimates of Central Blood Pressure in Patients with Severe Chronic Kidney Disease. Kidney & Blood Pressure Research. 44(4). 704–714. 5 indexed citations
14.
Laugesen, Esben, et al.. (2017). Evaluation of interarm blood pressure differences using the Microlife WatchBP Office in a clinical setting. Blood Pressure Monitoring. 22(3). 161–165. 9 indexed citations
15.
Funck, Kristian Løkke, et al.. (2017). Antiplatelet effect of aspirin during 24 h in patients with type 2 diabetes without cardiovascular disease. Thrombosis Research. 161. 1–6. 10 indexed citations
16.
17.
Rossen, Niklas B., Klavs Würgler Hansen, Søren Tang Knudsen, et al.. (2016). Estimates of arterial stiffness and central blood pressure in patients with type 2 diabetes: A comparison of SphygmoCor and Arteriograph. Artery Research. 16(C). 18–18. 1 indexed citations
18.
Laugesen, Esben, Jesper Fleischer, Søren Tang Knudsen, et al.. (2016). Reduced Subendocardial Viability Ratio Is Associated With Unfavorable Cardiovascular Risk Profile in Women With Short Duration of Type 2 Diabetes. American Journal of Hypertension. 29(10). 1165–1172. 26 indexed citations
19.
Østergaard, Jakob Appel, Esben Laugesen, & R. D. G. Leslie. (2016). Should There be Concern About Autoimmune Diabetes in Adults? Current Evidence and Controversies. Current Diabetes Reports. 16(9). 82–82. 19 indexed citations
20.
Laugesen, Esben, Jakob Appel Østergaard, & Richard David Leslie. (2015). Latent autoimmune diabetes of the adult: current knowledge and uncertainty. Diabetic Medicine. 32(7). 843–852. 112 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by B. Lormeau Breakdown of academic impact, for papers by Satoki Homma Breakdown of academic impact, for papers by Jye‐Yu C. Backlund Breakdown of academic impact, for papers by Amanda J. Cox Breakdown of academic impact, for papers by Xueqi Li Breakdown of academic impact, for papers by Valentina Milani Breakdown of academic impact, for papers by Yoshihiko Sakai Breakdown of academic impact, for papers by E Hartter Breakdown of academic impact, for papers by Jacek Kądziela Breakdown of academic impact, for papers by Jennifer Linge
Rankless by CCL
2026